Recombinant protein production for structural and kinetic studies: A case study using M. tuberculosis α-methylacyl-CoA racemase (MCR)
Methods in Enzymology · 2023
DOI: 10.1016/bs.mie.2023.07.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Methods in Enzymology, 2023. Verfasst von Otsile O Mojanaga und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, University of Bath, Claverton Down, Bath, United Kingdom. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 96 Literaturangaben.
Abstract (Originalsprache)
Modern drug discovery is a target-driven approach in which a particular protein such as an enzyme is implicated in the disease process. Commonly, small-molecule drugs are identified using screening, rational design, and structural biology approaches. Drug screening, testing and optimization is typically conducted in vitro, and copious amounts of protein are required. The advent of recombinant DNA technologies has resulted in a rise in proteins purified by affinity techniques, typically by incorporating an "affinity tag" at the N- or C-terminus. Use of these tagged proteins and affinity techniques comes with a host of issues. This chapter describes the production of an untagged enzyme, α-methylacyl-CoA racemase (MCR) from Mycobacterium tuberculosis, using a recombinant E. coli system. Purification of the enzyme on a 100 mg scale using tandem anion-exchange chromatographies (DEAE-sepharose and RESOURCE-Q columns), and size-exclusion chromatographies is described. A modified protocol allowing the purification of cationic proteins is also described, based on tandem cation-exchange chromatographies (using CM-sepharose and RESOURCE-S columns) and size-exclusion chromatographies. The resulting MCR protein is suitable for biochemical and structural biology applications. The described protocols have wide applicability to the purification of other recombinant proteins and enzymes without using affinity chromatography.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Sciences, University of Bath, Claverton Down, Bath, United Kingdom.
- Department of Life Sciences, University of Bath, Claverton Down, Bath, United Kingdom. Electronic address: K.R.Acharya@bath.ac.uk.
- Department of Life Sciences, University of Bath, Claverton Down, Bath, United Kingdom. Electronic address: M.D.Lloyd@bath.ac.uk.
Zitieren
APA
Mojanaga, O. O., Acharya, K. R., & Lloyd, M. D. (2023). Recombinant protein production for structural and kinetic studies: A case study using M. tuberculosis α-methylacyl-CoA racemase (MCR). Methods in Enzymology. https://doi.org/10.1016/bs.mie.2023.07.001
Vancouver
Mojanaga OO, Acharya KR, Lloyd MD. Recombinant protein production for structural and kinetic studies: A case study using M. tuberculosis α-methylacyl-CoA racemase (MCR). Methods in Enzymology. 2023. doi:10.1016/bs.mie.2023.07.001
BibTeX
@article{Mojanaga2023,
author = {Mojanaga, Otsile O and Acharya, K Ravi and Lloyd, Matthew D},
title = {Recombinant protein production for structural and kinetic studies: A case study using M. tuberculosis α-methylacyl-CoA racemase (MCR)},
journal = {Methods in Enzymology},
year = {2023},
doi = {10.1016/bs.mie.2023.07.001}
}
EUVIMED